胃癌的新辅助治疗  

Neoadjuvant therapy of gastric cancer

作　　者：姜虹[1] 王理伟[1] 

机构地区：[1]上海同济大学附属东方医院肿瘤中心,上海200120

出　　处：《世界肿瘤杂志》2006年第2期140-142,共3页Tumour Journal of the World

摘　　要：胃癌的预后极差，其死亡率居于所有癌症的第二位。尽管手术切除肿瘤是首选治疗方案，但术后死亡率仍高达60％以上。为了提高治愈性（RO）切除率，降低术后死亡率，延长生存期，提高生活质量，各国医学工作者进行了大量的研究。本文将对近年来胃癌新辅助治疗进展作一综述。The prognosis of gastric cancer is poor, which currently ranks second in global cancer mortality. Although surgery remains the only proven curative option for patients with localized gastric carcinoma, moer than 60% die of cancer following an curative resection（RO）. In an attempt to improve the R0 resection rate, reduce the rate of recurrence, and improve survival rates and quality of life, researchers all over the world have designed numerous trials investgating the potential utility of neoadjuvant therapy.

关 键 词：胃癌 新辅助治疗 放化疗 

分 类 号：R735.2[医药卫生—肿瘤] R730.5[医药卫生—临床医学]